CAS: 618-39-3; Benzimidamide

该化合物是一种小型有机化合物,其特征是附于苯乙烯环的宫底功能组;它被广泛用作对精液蛋白,特别是类似锥虫的酶的竞争性抑制剂,因为它能够模仿基质的或甘油边链.这种特性使它在生化研究和药物应用,包括酶抑制研究和药物开发中具有价值. 其普通盐形式是Benzamidine 盐,它提供了水溶液中的强化溶解性,便利其在缓冲系统中的使用. 化合物在生理条件下的特性和稳定性突出它在蛋白学和结构生物学研究中的效用.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号1670-14-0 苄脒盐酸盐 | CAS号100-09-4 对甲氧基苯甲酸 | CAS号94-09-7 对氨基苯甲酸乙酯 | CAS号5033-28-3 4-氯-N-羟基苯羧酰亚胺 | CAS号100-47-0 苯甲腈 | CAS号613-92-3 苄胺肟 | CAS号16118-22-2 N-Benzylideneamine | CAS号76843-75-9 1,5-Dithia-2,4,... | CAS号930-69-8 苯硫酚钠 | CAS号4222-25-7 3-bromo-3-pheny... | CAS号38696-20-7 5-溴-2-苯基嘧啶 | CAS号93-89-0 苯甲酸乙酯 | CAS号100-46-9 苄胺 | CAS号142965-56-8 4-methyl-2-phen... | CAS号14945-93-8 4-methylsulfany... | CAS号24108-37-0 1,2,4-Triazine,... | CAS号493-77-6 2,4,6-三苯基三嗪 | CAS号78386-71-7 2,4-di-phenyl-6... | CAS号78386-69-3 3,5-diphenyl-6-... | CAS号1046-56-6 5,6-二苯基-3-(2-吡啶...

合成工艺路线路线简述

    O-(2-Amino-3-Methyl-Butyryl)Benzamidoxime Dihydrochloride置于carboxyl Esterase,Cytochrome B5,Nadh Cytochrome B5 Reductase,Human Amidoxime Reducing Component 1,还原型辅酶ii(Nadph)四钠盐体系中,化学反应 0.5H,反应生成 苯甲脒
    参考文献:Synthesis And Biological Evaluation Of L-Valine-Amidoximeesters As Double Prodrugs Of Amidines
    标题:Synthesis And Biological Evaluation Of L-Valine-Amidoximeesters As Double Prodrugs Of Amidines
    摘要:In General,Drugs Containing Amidines Suffer From Poor Oral Bioavailability And Are Often Converted Into Amidoxime Prodrugs To Overcome Low Uptake From The Gastrointestinal Tract. The Esterification Of Amidoximes With Amino Acids Represents A Newly Developed Double Prodrug Principle Creating Derivatives Of Amidines With Both Improved Oral Availability And Water Solubility. N-Valoxybenzamidine (1) Is A Model Compound For This Principle,Which Has Been Transferred To The Antiprotozoic Drug Pentamidine (8). Prodrug Activation Depends On Esterases And Marc And Is Thus Independent From Activation By P450 Enzymes. Therefore,Drug-Drug Interactions Or Side Effects Will Be Minimized. The Synthesis Of These Two Compounds Was Established,And Their Biotransformation Was Studied In Vitro And In Vivo. Bioactivation Of N-Valoxybenzamidine (1) And N,N'-Bis(Valoxy)Pentamidine (7) Via Hydrolysis And Reduction Has Been Demonstrated In Vitro With Porcine And Human Subcellular Enzyme Preparations And The Mitochondrial Amidoxime Reducing Component (Marc). Moreover,Activation Of N-Valoxybenzamidine (1) By Porcine Hepatocytes Was Studied. In Vivo,The Bioavailability In Rats After Oral Application Of N-Valoxybenzamidine (1) Was About 88%. Similarly,N,N'-Bis(Valoxy)Pentamidine (7) Showed Oral Bioavailability. Analysis Of Tissue Samples Revealed High Concentrations Of Pentamidine (8) In Liver And Kidney. (C) 2011 Elsevier Ltd. All Rights Reserved.
    DOI:10.1016/j.Bmc.2011.01.066

    海关参考信息

    郑州手性药物研究院有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chiralspharm.cn
    企业联系电话:0371-55219111👤
    📞郑州手性药物研究院有限公司 ⚠️参考联系方式
    联系人:李经理
    电话:0371-55219111
    手机:13703711903
    传真:0371-55219111
    邮箱:chiraldrug01@zzcpi.org
    通信地址: 郑州市中原西路中原智谷2号楼研发中心15层
    邮编: 450121
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:郑州市中原西路中原智谷2号楼研发中心15层
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献

    合成方法参考DOI号:10.1002/adsc.202100142
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知